Key result
Anticoagulation linked to a ~300% increase in occult GI bleeding, often revealing undiagnosed intestinal lesions.
Why the study?
Does anticoagulation therapy increase the prevalence of occult gastrointestinal bleeding, and what are the underlying causes?
Cohort (n=249)
Does anticoagulation therapy increase the prevalence of occult gastrointestinal bleeding, and what are the underlying causes?
Absolute Event Rate: 12% vs 3%
Occult gastrointestinal bleeding in anticoagulated patients should prompt diagnostic evaluation, as it frequently unmasks previously undiagnosed significant intestinal disease rather than being solely attributable to the anticoagulant.
No takes yet. Share an insight, caveat, or question.
Occult GI bleeding in anticoagulated patients may unmask lesions; extends observational data but leaves open screening impact.
Jaffin et al. (1987) conducted a cohort in Patients receiving anticoagulation therapy (n=249). Anticoagulation therapy vs. No anticoagulation therapy was evaluated on Occult gastrointestinal bleeding. Anticoagulation therapy was associated with occult gastrointestinal bleeding in 12% of patients compared to 3% of controls, often revealing previously undiagnosed intestinal lesions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: